LINC00857 and urinary bladder carcinoma: To investigate the role of LINC00857 in bladder cancer, an siRNA20 was used to knock down its expression in 2 muscle‐invasive bladder cancer‐derived cell lines, T24 and UM‐UC‐3 (Figure 2A).